HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Caramel Case: Federal Preemption Would Be Sweet, Prop 65 The Sundae

This article was originally published in The Rose Sheet

Executive Summary

The federal/state regulatory disconnects under California’s Prop 65 – a priority target in the cosmetics industry’s preemption explorations on Capitol Hill – are distinctly embodied by caramel, a color additive approved by FDA that nevertheless may require warnings on products sold in the Golden State.

You may also be interested in...



California’s Advancing Cosmetic Animal-Test Ban Poses Liabilities, Industry Says

Universities and other accredited labs often test cosmetic ingredients on animals to assess potential health risks without manufacturers’ involvement or even their knowledge. Under a proposed bill advancing in California, such studies could render companies that use those ingredients non-compliant and subject to fines.

‘California’s A Problem,’ But Prop 65 Preemption For Cosmetics Could Be Out Of Reach

California is the poster child for regulation in excess of federal requirements, but the biggest challenges it poses to cosmetics companies will be difficult – if not impossible – to resolve via “national uniformity” provisions in legislation before Congress.

‘Something’s Going To Happen’: Former FDAer John Bailey On Cosmetics Reform Legislation

ICMAD leadership agrees with Bailey that, now more than ever before, the pieces are in place for cosmetics reform legislation to reach the finish line. At the same time, the small-business advocate remains opposed to leading proposals, signaling the significant distance that negotiations may still have to go.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel